CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6-serotonin-dopamine crosstalk revisited.

Ozdemir V, Bertilsson L, Miura J, Carpenter E, Reist C, Harper P, Wid?n J, Svensson JO, Albers LJ, Kennedy JL, Endrenyi L, Kalow W. CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6-serotonin-dopamine crosstalk revisited. Pharmacogenet Genomics. 2007 May; 17(5):339-47.

View in: PubMed

subject areas

Adult
Antipsychotic Agents
Cytochrome P-450 CYP2D6
Dopamine
Dopamine Agents
Double-Blind Method
Drug Interactions
Female
Genotype
Homozygote
Humans
Male
Perphenazine
Pituitary Gland
Placebos
Polymorphism, Genetic
Prolactin
Prospective Studies
Serotonin
Serotonin Agents

authors with profiles

Lawrence J. Albers, MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support